Key Insights into the Gastroesophageal Reflux Disease (GERD) Market: Trends, Growth Rate, and Opportunities Through 2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gastroesophageal Reflux Disease (GERD) Market?
The rising occurrence of diseases affecting the esophagus could accelerate the development of the gastroesophageal reflux disease (GERD) market. These ailments affect the tube connecting the mouth and stomach and their treatment is centred around mitigating symptoms, enhancing life quality, and averting related issues to boost overall health and wellness. As an example, the American Cancer Society reported that in January 2023, about 21,560 new esophageal cancer instances were diagnosed in the U.S annually, with 16,120 deaths resulting from esophageal cancer. So, the increasing instances of esophageal diseases are contributing to the growth of the gastroesophageal reflux disease (GERD) market.
The Influence Of Alcohol In Fueling The Gastroesophageal Reflux Disease (GERD) Market
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp
#What is the Projected CAGR for the Gastroesophageal Reflux Disease (GERD) Market Size from 2025 to 2034?
There has been minor growth in the market size of gastroesophageal reflux disease (GERD) in the past few years. A rise from $5.25 billion to $5.35 billion is forecasted between 2024 and 2025, which signifies a compound annual growth rate (CAGR) of 2.0%. The growth observed in the past is a result of factors such as lifestyle and diet modifications, rampant obesity, heightened awareness about GERD therapy, the worldwide expansion of the pharmaceutical industry, and investments channelled towards GERD treatments.
Anticipated to experience consistent expansion in the coming years, the market for gastroesophageal reflux disease (GERD) is projected to reach $5.94 billion by 2029 with a compound annual growth rate (CAGR) of 2.7%. Factors contributing to this forecasted growth include an aging demographic, increase in healthcare expenditure, the advent of biomarkers, rising number of GERD screening programs, a growing incidence of heartburn, and an enhanced demand for medical machinery. Significant trends to watch for in this period include advancements in diagnostic and surgical methods, the emergence of targeted treatment approaches, and the increased utilization of telehealth services.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12917
What Are the Key Market Innovations in theGastroesophageal Reflux Disease (GERD) Market Over the Coming Years?
Leading firms in the gastroesophageal reflux disease (GERD) market are concentrating their efforts on the launch of groundbreaking GERD treatment devices, in order to preserve their market standing. Laborie Medical Technologies, a medical technology firm based in the US, for example, unveiled its pioneering alpHaONE wireless pH-capsule reflux testing diagnostic system in April 2023. This system, specifically created for the diagnosis of GERD, can capture up to 96 hours’ worth of monitoring data and boasts compact construction, enlarged buttons, and an infallible capsule delivery system. This system also incorporates a software app with a virtual instructional program and personalized symptom buttons to enhance user experience.
Who Are the Top Companies Driving Innovation and Growth in theGastroesophageal Reflux Disease (GERD) Market?
Major companies operating in the gastroesophageal reflux disease (GERD) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd.
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Gastroesophageal Reflux Disease (GERD) Market and Drive Its Revenue Growth?
The gastroesophageal reflux disease (GERD) market covered in this report is segmented –
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty Clinics
Subsegments:
1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine
4) By Prokinetic Agents: Metoclopramide, Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol
6) By EndoCinch: Endoscopic Suturing Systems
7) By Stretta: Radiofrequency Ablation Systems
8) By EsophyX: Transoral Fundoplication Systems
9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12917&type=smp
Which Regions Are Emerging as Leaders in the Gastroesophageal Reflux Disease (GERD) Market?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Gastroesophageal Reflux Disease (GERD) Market 2025, By The Business Research Company:
Inflammatory Bowel Disease Treatment Global Market Report 2024
Digestive Health Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-health-global-market-report
Digestive Health Supplements Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-health-supplements-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
